Particulars (Rupees in Crores.) | Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 |
---|---|---|---|---|---|
Gross Sales | 1,858.8 | 1,681.2 | 1,525.9 | 1,601.9 | 1,150.3 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,858.8 | 1,681.2 | 1,525.9 | 1,601.9 | 1,150.3 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 67.6 | 50.8 | 27.5 | 40.5 | 37.8 |
Total Income | 1,926.4 | 1,732 | 1,553.4 | 1,642.4 | 1,188.1 |
Total Expenditure | 1,332.3 | 1,216.6 | 1,151.6 | 1,162.3 | 836 |
PBIDT | 594.1 | 515.4 | 401.8 | 480.1 | 352.1 |
Interest | 17.3 | 22.8 | 28.5 | 18.3 | 11.6 |
PBDT | 576.8 | 492.6 | 373.3 | 461.8 | 340.5 |
Depreciation | 105.5 | 107 | 112.6 | 70.4 | 56.9 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 132.7 | 115.4 | 84.9 | 107.8 | 76.5 |
Deferred Tax | 1.9 | -6.3 | -8.4 | -4.6 | -4.3 |
Reported Profit After Tax | 336.7 | 276.5 | 184.2 | 288.2 | 211.4 |
Minority Interest After NP | 4.4 | 3.3 | 2 | 4.7 | 3.2 |
Net Profit after Minority Interest | 332.3 | 273.2 | 182.2 | 283.5 | 208.2 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 332.3 | 273.2 | 182.2 | 283.5 | 208.2 |
EPS (Unit Curr.) | 39.91 | 32.88 | 22 | 34.27 | 25.23 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 180 | 0 | 0 | 0 | 120 |
Equity | 83.6 | 83.5 | 83.4 | 83.3 | 83.3 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 31.96 | 30.65 | 26.33 | 29.97 | 30.6 |
PBDTM(%) | 31.03 | 29.3 | 24.46 | 28.82 | 29.6 |
PATM(%) | 18.11 | 16.44 | 12.07 | 17.99 | 18.37 |
Dr Lal PathLabs declared a fourth interim dividend of ₹6 per share for 2025, reflecting its strong cash generation and shareholder remittance focus.
The company declared a third interim dividend of ₹6 per share (60% on a face value of ₹10) for FY25.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.